1. Pink Sheet
  2. >>Geography
  3. >>Europe

NICE Launches ‘Concierge System’ To Guide Companies Through HTA Process

 
• By Eliza Slawther

The health technology assessment body for England and Wales has launched an integrated, flexible advice portal to help guide companies through its potentially “bewildering” health system.

Sharmila Nebhrajani, NICE chair, speaking at the NICE annual conference 2023
Sharmila Nebhrajani, NICE chair, at the NICE annual conference 2023 • Source: Pink Sheet

Pharmaceutical, biotech and medtech companies looking to enter the UK market can now benefit from scientific and strategic advice that is “easier to access” and more flexible than the former support service offered by the health technology assessment (HTA) body for England and Wales, NICE.

Dubbed ‘NICE Advice’, the refreshed support portal functions as a “single front door” for drug developers and healthtech firms to use when seeking funding for their products on the National Health Service, the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.

Commission Taking ‘Due Account’ Of Scathing Report On EU Clinical Trial Bottlenecks

 
• By Vibha Sharma

A report by the European pharmaceutical industry criticizes the EU’s clinical trials framework, highlighting regulatory fragmentation, inefficiencies and the need for targeted reforms.

EU Moment Of Truth For Obe-Cel And 10 Other New Medicines

 
• By Neena Brizmohun

Autolus’s CAR T therapy obe-cel is among the medicines that are this week due for an opinion by the European Medicines Agency on whether they should be marketed in the EU.

More from Geography

HHS Negotiating With Manufacturers On Most Favored Nation Drug Pricing

 
• By Cathy Kelly

MFN policy would would apply to all single source drugs in all insurance markets, according to HHS release. Secretary Robert F. Kennedy Jr. said the department is discussing the plan with drug sponsors.

Spain Slashes Wait Between EU Drug Authorization And Financing Decisions

 
• By Francesca Bruce

Spanish authorities say that that timelines for drug reimbursement decisions can be improved further with the right submissions from companies.

Spain Beats England To Tevimbra Reimbursement Recommendations

 
• By Francesca Bruce

Spanish authorities have published more pricing and reimbursement reports as part of a new drive to increase transparency.